BMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)
Source: SeekingAlpha
2026-05-28 05:40:03 ET
Overview
The BlackRock Health Sciences Term Trust ( BMEZ ) offers investors a way to get instant diversification across a portfolio of health care companies. However, I issued a sell rating at the time of my last coverage because of its poor NAV growth and underperformance against peers. However, the fund has released an updated annual report, and there may be a renewed growth catalyst over the next few years. Therefore, I wanted to take a more focused look at the fund and reassess its current value proposition for investors....
Read the full article on Seeking Alpha
For further details see:
BMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)
BlackRock Health Sciences Term Trust of Beneficial Interest
NASDAQ: BMEZ
BMEZ Trading
1.74% G/L:
$14.64 Last:
219,134 Volume:
$14.58 Open:
BMEZ Latest News
May 19, 2026 05:00:45 am
The Interest Rate "Surprise" Everyone's Ignoring (and the 10.3% Dividend That Profits From it)
BMEZ Stock Data
$200,928,581
12,560,000
N/A
118
N/A
Asset Management Services
Finance
US
Wilmington
